CSI Market
Sign In | Register

Abcellera Biologics Inc (ABCL) Annual Balance Sheets

Annual · GAAP · USD millions
Access ABCL quarterly Balance Sheets →
The balance sheet figures below highlight longer-term patterns in how Abcellera Biologics Inc finances operations and invests in assets.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent0.00
Available-for-sale Securities, Debt Securities MA405.31
Cash & Short-term Investments405.00
Other Current Assets194.41
Total Current Assets728.23
Equipment/Property/Plant Net0.00
Goodwill net47.81
Intangible Assets38.38
Long-term investments62.58
Other Assets, Noncurrent542.53
Cash Cash Equivalents And Marketable Securities-
Accounts And Accrued Receivable Current58.29
Total Assets1,356.95
Liabilities
Accounts Payable and Other Accrued Liabilities, Current50.78
Accrued Liabilities, Current0.00
Other Liabilities, Current0.00
Accrued Income Taxes, Current TA0.00
Business Combination, Contingent Consideration, Liability, Current BU0.00
Total Current Liabilities64.31
Total Long-term Debt0.00
Other liabilities, Noncurrent325.74
Contract With Customer Liability Current13.53
Operating Lease Liability Noncurrent137.40
Deferred Revenue And Grant Funding Noncurrent-
Deferred Income Tax Liabilities Net9.12
Total Liabilities390.05
Stockholders' Equity
Common Stock Value802.34
Additional Paid In Capital Common Stock198.28
Retained Earnings / Accumulated Deficit-29.48
Other Equity-4.23
Common Stockholder's Equity966.90
Total Stockholder's Equity966.90
Liabilities & Stockholder's Equity1,356.95
4 historic quarters locked

Sign in to unlock the full Abcellera Biologics Inc balance sheet history.

Sign In Create Free Account

About Abcellera Biologics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 24, 2026
  • Source: abcl-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001703057-26-000012

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.